EU study shows decrease in problematic patent settlements
Tuesday, 6 July 2010
The number of patent settlements in the pharmaceutical sector that could violate European competition rules fell by 12 per cent last year, according to a study by the European Commission.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top